MAZE Maze Therapeutics, Inc.

Fundamentals / CIK 0001842295 / USD

Maze Therapeutics, Inc. reported $511.6M in total assets and a net loss of $151.5M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open MAZE in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

2 fiscal years (2024 to 2025), reported in USD.

$178.9M$89.47M$0-$136.8MFY 2024 Revenue: $167.5MFY 2024 Net Income: $52.23M2024FY 2025 Net Income: -$131.1M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31
Revenue -- $167.5M
Research & Development $108.4M $83.50M
Total Operating Expenses $142.9M $109.9M
Operating Income -$142.9M $57.59M
EBITDA -$140.5M $60.88M
Income Before Tax -$131.1M $53.40M
Income Tax Expense $0 $1.17M
Net Income -$131.1M $52.23M
Basic EPS -$3.05 $1.42
Diluted EPS -$3.05 $1.25
Basic Shares Outstanding 43.0M 2.4M
Diluted Shares Outstanding 43.0M 2.7M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $0 $0 $20.00M -- -- $0 -- --
Research & Development $40.22M $34.94M $34.15M $27.57M $25.19M $28.11M $27.58M $22.22M
Total Operating Expenses $51.52M $48.03M $46.55M $38.06M $32.97M $36.47M $35.40M $29.73M
Operating Income -$51.52M -$48.03M -$26.55M -$38.06M -$32.97M -$36.47M -$35.40M -$29.73M
EBITDA -$51.13M -$47.64M -$26.11M -$37.56M -$32.39M -$35.83M -$34.72M -$29.02M
Interest Expense $975K $931K $866K -- -- -- -- --
Income Before Tax -- -- -- -$34.57M -$30.09M -$33.68M -$32.79M -$29.85M
Income Tax Expense -- -- -- -- $0 $0 -- --
Net Income -$47.97M -$44.73M -$24.21M -$34.57M -$30.09M -$33.68M -$32.79M -$29.58M
Basic EPS -$0.79 -$0.76 -$0.45 -- -$0.66 -$0.77 -$1.15 --
Diluted EPS -$0.79 -$0.76 -$0.45 -- -$0.66 -$0.77 -$1.15 --
Basic Shares Outstanding 60.9M 59.0M 53.9M -- 45.8M 43.8M 28.6M --
Diluted Shares Outstanding 60.9M 59.0M 53.9M -- 45.8M 43.8M 28.6M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31
Cash & Cash Equivalents $189.2M $196.8M
Short-Term Investments $152.7M --
Cash & Short-Term Investments $341.9M $196.8M
Total Current Assets $349.7M $201.7M
Property, Plant & Equipment, Net $5.04M $6.67M
Long-Term Investments $18.11M --
Other Non-Current Assets $3.05M $7.87M
Total Non-Current Assets $47.41M $38.87M
Total Assets $397.1M $240.5M
Accounts Payable $1.79M $1.94M
Total Current Liabilities $22.56M $20.67M
Other Non-Current Liabilities $1.09M $969K
Total Non-Current Liabilities $19.61M $22.96M
Total Liabilities $42.16M $43.64M
Total Debt (incl. Leases) $23.31M $26.63M
Common Stock $49K $2.0K
Retained Earnings -$489.5M -$358.4M
Total Stockholders' Equity $355.0M -$311.2M
Total Equity $355.0M -$311.2M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $154.2M $202.6M $198.8M $189.2M $316.8M $264.5M $294.4M $196.8M
Short-Term Investments $235.5M $208.4M $153.6M $152.7M $67.16M -- -- --
Cash & Short-Term Investments $389.7M $411.1M $362.9M $341.9M $383.9M $264.5M $294.4M $196.8M
Accounts Receivable, Net -- -- $20.00M -- -- -- -- --
Total Current Assets $400.1M $420.4M $379.8M $349.7M $391.3M $271.1M $299.7M $201.7M
Property, Plant & Equipment, Net $4.35M $4.39M $4.68M $5.04M $5.54M $6.01M $6.31M $6.67M
Long-Term Investments $87.32M $83.82M $10.56M $18.11M -- -- -- --
Other Non-Current Assets $1.10M $3.46M $4.32M $3.05M $3.21M $3.57M $3.25M $7.87M
Total Non-Current Assets $111.5M $111.2M $39.93M $47.41M $30.76M $32.37M $33.13M $38.87M
Total Assets $511.6M $531.6M $419.7M $397.1M $422.1M $303.5M $332.8M $240.5M
Accounts Payable $4.57M $2.21M $4.01M $1.79M $2.92M $3.67M $2.40M $1.94M
Short-Term Debt $0 $0 $0 -- -- -- -- --
Total Current Liabilities $28.30M $22.96M $21.24M $22.56M $22.11M $19.90M $18.62M $20.67M
Long-Term Debt $39.12M $38.96M $38.83M -- -- -- -- --
Other Non-Current Liabilities -- -- $388K $1.09M $1.09M $1.09M $1.01M $969K
Total Non-Current Liabilities $54.71M $55.54M $56.77M $19.61M $20.51M $21.38M $22.16M $22.96M
Total Liabilities $83.01M $78.50M $78.01M $42.16M $42.62M $41.28M $40.77M $43.64M
Total Debt (incl. Leases) $59.64M $60.42M $61.22M $23.31M $24.18M $25.01M $25.82M $26.63M
Common Stock $56K $56K $50K $49K $48K $44K $44K $2.0K
Retained Earnings -$606.5M -$558.5M -$513.8M -$489.5M -$455.0M -$424.9M -$391.2M -$358.4M
Total Stockholders' Equity $428.5M $453.1M $341.7M $355.0M $379.4M $262.2M $292.1M -$311.2M
Total Equity $428.5M $453.1M $341.7M $355.0M $379.4M $262.2M $292.1M -$311.2M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31
Net Income -$131.1M $52.23M
Depreciation & Amortization $2.40M $3.30M
Stock-Based Compensation $16.40M $9.65M
Change in Payables -$27K -$204K
Operating Cash Flow -$111.9M $75.95M
Capital Expenditure -$794K -$1.15M
Free Cash Flow -$112.7M $74.81M
Purchases of Investments -$187.7M --
Investing Cash Flow -$171.0M -$1.15M
Financing Cash Flow $275.3M $92.85M
Net Change in Cash -$7.57M $167.7M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$47.97M -$44.73M -$24.21M -$34.57M -$30.09M -$33.68M -$32.79M -$29.58M
Depreciation & Amortization $385K $391K $444K $499K $571K $649K $684K $705K
Stock-Based Compensation $8.54M $9.19M $7.11M $6.07M $3.86M $3.24M $3.23M $2.85M
Change in Receivables -- -- -$20.00M -- -- -- -- --
Change in Payables $2.35M -$1.79M $2.21M -$1.12M -$748K $1.27M $579K $821K
Operating Cash Flow -$32.84M -$15.05M -$39.11M -$27.73M -$24.64M -$30.05M -$29.52M -$22.45M
Capital Expenditure -$288K -$107K -$93K -$34K -$68K -$393K -$299K -$605K
Free Cash Flow -$33.13M -$15.16M -$39.21M -$27.76M -$24.71M -$30.45M -$29.82M -$23.06M
Purchases of Investments -$68.12M -$162.4M -$23.63M -- -- -- -- --
Investing Cash Flow -$31.41M -$128.5M $6.28M -$103.4M -$66.88M -$393K -$299K -$605K
Financing Cash Flow $15.77M $147.4M $42.36M $3.59M $143.8M $612K $127.4M $70.26M
Net Change in Cash -$48.49M $3.88M $9.52M -$127.5M $52.23M -$29.83M $97.56M $47.20M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31
Operating Margin -- 34.4%
Net Profit Margin -- 31.2%
Return on Equity (ROE) -36.9% --
Return on Assets (ROA) -33.0% 21.7%
Current Ratio 15.50x 9.76x
Quick Ratio 15.16x 9.52x
Debt to Equity 0.07x --
Operating Income Growth (YoY) -348.1% --
Net Income Growth (YoY) -351.0% --
EPS Growth (YoY) -314.8% --
Operating Cash Flow Growth (YoY) -247.4% --
Free Cash Flow Growth (YoY) -250.7% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -35.3% -29.5% -35.9% -36.9% -33.2% -46.1% 17.8% --
Return on Assets (ROA) -29.6% -25.1% -29.2% -33.0% -29.9% -39.8% 15.6% 21.7%
Current Ratio 14.14x 18.31x 17.88x 15.50x 17.70x 13.63x 16.10x 9.76x
Quick Ratio 13.77x 17.90x 18.03x 15.16x 17.36x 13.29x 15.81x 9.52x
Debt to Equity 0.14x 0.13x 0.18x 0.07x 0.06x 0.10x 0.09x --
Revenue Growth (YoY) -- -- -- -- -- -100.0% -- --
Operating Income Growth (YoY) -- -- -- -- -- -126.1% -- --
Net Income Growth (YoY) -- -- -- -- -- -124.2% -- --
EPS Growth (YoY) -- -- -- -- -- -113.0% -- --
Operating Cash Flow Growth (YoY) -- -- -- -- -- -120.7% -- --
Free Cash Flow Growth (YoY) -- -- -- -- -- -121.0% -- --
Source: SEC EDGAR CompanyFacts (CIK 0001842295) · from March 31, 2024 Data through September 30, 2026 · synced Nov 20, 2026, 05:23 UTC · Open in terminal